Relationship between SCL-90, Maudsley Personality Inventory and CCK4- induced intracellular calcium response in T cells

Psychiatry Research

Volumn 81, Issue 3, 1998, Pages 381-386

  Akiyoshi, Jotaro ^a   Yamauchi, Chiyo ^a   Furuta, Mariko ^a   Katsuragi, Satomi ^a   Kohno, Yoshiko ^a   Yamamoto, Yukiko ^a   Miyamoto, Masafumi ^a   Tsutsumi, Takashi ^a   Isogawa, Koichi ^a   Fujii, Isao ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Calcium; Cholecystokinin; Intracellular calcium mobilization; Maudsley Personality Inventory; SCL 90; T cells

Indexed keywords

TETRAGASTRIN;

ADULT; ARTICLE; CALCIUM CELL LEVEL; FEMALE; HUMAN; MALE; NORMAL HUMAN; PARANOIA; PERSONALITY; PRIORITY JOURNAL; SEX DIFFERENCE; T LYMPHOCYTE;

ADULT; ANXIETY DISORDERS; CALCIUM; CALCIUM CHANNELS; EXTRAVERSION (PSYCHOLOGY); FEMALE; HUMANS; INTROVERSION (PSYCHOLOGY); MALE; PERSONALITY DISORDERS; PERSONALITY INVENTORY; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; T-LYMPHOCYTES; TETRAGASTRIN;

EID: 0032517871     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(98)00116-4     Document Type: Article

References (35)

1. Akiyoshi J., Nishizono A., Yamada K., Nagayama H., Mifune K., Fujii I. Rapid desensitization of serotonin 5-HT2C receptor-stimulated intracellular calcium mobilization in CHO cells transfected with cloned human 5-HT2C receptors. Journal of Neurochemistry. 6:1995;2473-2479.
2. Akiyoshi J., Moriyama T., Isogawa K., Miyamoto M., Sasaki I., Kuga K., Yamamoto H., Yamada K., Fujii I. CCK-4 induced calcium mobilization in T cells is enhanced in panic disorder. Journal of Neurochemistry. 66:1996;1610-1616.
3. Akiyoshi J., Isogawa K., Tsutsumi T., Katsuragi S., Kohno K., Furuta M., Yamamoto Y., Yamada K., Fujii I. Cholecystokinin tetrapeptide-induced calcium mobilization in T cells of patients with panic disorder, major depression, or schizophrenia. Biological Psychiatry. 42:1997;151-154.
4. Altar C.A., Boyar W.C., Oei E., Wood P.L. Cholecystokinin attenuates basal and drug-induced increases in limbic and striatal dopamine release. Brain Research. 460:1988;76-82.
5. Aluoja A., Shlik J., Vasar V., Kingisepp P.-H., Jagomagi K., Vasar E., Bradwejn J. Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers. Psychiatry Research. 66:1997;59-67.
6. Benjamin J., Li L., Patterson C., Greenberg B.D., Murphy D.L., Hamer D.H. Population and familial associations between the D4 dopamine receptor gene and measures of novelty seeking. Nature Genetics. 12:1996;81-84.
7. Bradwejn L., Koszycki D. Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder. American Journal of Psychiatry. 151:1994;261-263.
8. Bradwejn L., Koszycki D., Shriqui C. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings. Archives of General Psychiatry. 48:1991;603-610.
9. Crawley J.N. Cholecystokinin-dopamine interaction. Trends in Pharmacological Sciences. 12:1991;232-236.
10. Crawley J.N., Stivers J.A., Blumstein L.K., Paul S.M. K Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence. Journal of Neuroscience. 5:1985;1972-1983.
11. Cuq P., Gross A., Terraza A., Fourmy D., Clerc P., Dornand J., Magous R. mRNAs encoding CCKB but not CCKA receptors are expressed in human T lymphocytes and Jurkat lymphoblastoid cells. Life Sciences. 61:1997;543-555.
12. De Montigny C. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Archives of General Psychiatry. 46:1989;511-517.
13. Derogatis, L.R., 1977. SCL: Administration, Scoring and Procedures Manual for the Revised Version. Clinical Psychometric Research, Baltimore.
14. Derogatis L.R., Lipman R.S., Covi L. SCL-90: an outpatient psychiatric rating scale - preliminary report. Psychopharmacology Bulletin. 9:1973;13-28.
15. Derogatis L.R., Rickels K., Rock A.F. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. British Journal of Psychiatry. 128:1976;280-289.
16. De Witte P., Heibreder C., Roques B., Vanderhaeghen J.J. Opposite effects of cholecystokinin octapeptide (CCK-8) and tetrapeptide (CCK-4) after injection into the caudal part of the nucleus accumbens or into its rostral part and the cerebral ventricles. Neurochemical International. 10:1987;473-479.
17. Dornand J., Roche S., Michel F., Bali J.P., Cabane S., Favero J., Magous R. Gastrin-CCK-B type receptors on human T lymphoblastoid Jurkat cells. American Journal of Physiology. 268:1995;G522-G529.
18. Ebstein R.P., Novick O., Umansky R., Priel B., Osher Y., Blaine D., Benette E.R., Nemanov L., Katz M., Belmaker R.H. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nature Genetics. 12:1996;78-80.
19. Eysenck, H.J., 1959. Manual of the Maudsley Personality Inventory. University of London Press, London.
20. Fallon J.H., Hicks R., Loughlin S.E. The origin of cholecystokinin terminals in the basal forebrain of the rat: evidence from immuno-fluorescence and retrograde tracing. Neuroscience Letters. 37:1983;29-35.
21. Fourmy D., Zahidi A., Fabre R., Guidet M., Pradayrol L., Ribet A. Receptors for cholecystokinin and gastrin peptides display specific binding properties and are structurally different in guinea-pig and dog pancreas. European Journal of Biochemistry. 165:1987;683-692.
22. Harro J., Pold M., Vasar E. Anxiogenic-like action of caerulein, a CCK-8 receptor antagonist, in the mouse: influence of acute and subchronic diazepam treatment. Naunyn-Schmiedeberg's Archives of Pharmacology. 341:1990;62-67.
23. Hokfelt T., Rehfeld J.F., Skirboll L., Ivemark B., Goldstein M., Markey K. Evidence for coexistence of dopamine and CCK in meso-limbic neurons. Nature. 285:1980;476-478.
24. Hokfelt, T., Skirboll, L., Everitt, B., Meister, B., Brownstein, M., Jacobs, T., Faden, A., Kuga, S., Goldstein, M., Markstein, R., Dockray, G., Rehfeld, J., 1985. Distribution of cholecystokinin-like immunoreactivity in the nervous system. In: Vanderhaeghen, J.J., Crawley, J.N. (Eds.), Neuronal Cholecystokinin. New York Academy of Sciences, New York, pp. 255-274.
25. Hsiao S., Katsuura G., Itoh S. Cholecystokinin tetrapeptide proglumide and open-field behavior in rats. Life Sciences. 34:1984;2165-2168.
26. Ingram S.M., Krause R.G., Baldino F., Skeen L.C., Lewis M.E. Neuronal localization of cholecystokinin mRNA in the rat brain by using in situ hybridization histochemistry. Journal of Comparative Neurology. 287:1989;260-272.
27. Koszycki D., Zacharko R.M., Bradwejn J. Influence of personality on behavioral response to cholecystokinin-tetrapeptide in patients with panic disorder. Psychiatry Research. 62:1996;131-138.
28. Lee Y.M., Beinborn M., McBride E.W., Lu M., Kolakowski L.F. Jr., Kopin A.S. The human brain cholecystokinin-B/gastrin receptor. Journal of Biological Chemistry. 266:1993;8164-8169.
29. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 274:1997;1527-1531.
30. Marshall F.H., Barnes S., Hughes J., Woodruff G.N., Hunter J.C. Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms. Journal of Neurochemistry. 10:1991;3695-3700.
31. Rehfeld J.F. Neuronal cholecystokinin: one or multiple transmitters? Journal of Neurochemistry. 44:1985;1-10.
32. Uvnas-Moberg K., Arn I., Theörell T., Jonsson C.-O. Personality traits in a group of individuals with functional disorders of the gastrointestinal tract and their correlation with gastrin, somatostatin and oxytocin levels. Journal of Psychosomatic Research. 35:1991;515-523.
33. Uvnas-Moberg K., Arn I., Jonsson C.-O., Ek S., Nilsonne A. The relationships between personality traits and plasma gastrin, cholecystokinin, somatostatin, insulin, and oxytocin levels in healthy women. Journal of Psychosomatic Research. 37:1993;581-588.
34. Van Megen H.J.G.M., Westenberg H.G.M., Den Boer J.A. Effect of the selective serotonin reuptake inhibitor (SSRI) fluvoxamine on CCK-4 induced panic attacks. CINP 1994. Psychopharmacology. 10:1994;270.
35. Vasar E., Peuranen E., Harro J., Lang A., Oreland L., Mannisto P.T. Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein. Naunyn-Schmiedeberg's Archives of Pharmacology. 348:1993;96-101.